The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

• Status: Completed
• Trial end date: 1969-12-31

Summary

To evaluate the virologic effect of combined administration of zidovudine and ddI or ddC. To evaluate the immunologic effects of zidovudine and ddI or ddC. To evaluate combined administration of zidovudine and ddI or ddC for clinical efficacy. To evaluate the safety and the tolerance of the coadministration of zidovudine and ddI or ddC.

• Phase: N/A

Details

• Lead Sponsor: Glaxo Wellcome
• Treatments: Antiviral Agents; Didanosine; Zalcitabine; Zidovudine